Frost & Sullivan: Innovative Information Technology Awakens the Sleep Disorder Diagnostic Industry

Documents
5 Pages
Read an excerpt
Gain access to the library to view online
Learn more

Description

Frost & Sullivan: Innovative InformationFrost & Sullivan: Innovative Information Technology Awakens the Sleep Disorder Diagnostic Industry PR Newswire LONDON, March 11, 2014 - Sales of ambulatory polysymnogram devices far outstrip sales of clinical devices A large pool of undiagnosed patients and the growing population of the elderly in both Europe and North America point to a massive end-user market for sleep disorder diagnostics devices. The market is steadily drawing investors due to the visible tilt in preference from drugs to home care sleep tests that are more convenient and lack side effects. New analysis from Frost & Sullivan US & European Market for Sleep Disorder Diagnostic Devices finds that the market earned revenue of $95.6 million in 2013 and estimates this to reach $125.8 million in 2017. The diagnostic devices covered in this research include clinical polysymnogram (PSG) and ambulatory PSG systems. Information technology is playing an increasingly important role in the transformation of the sleep disorder treatment market. Disruptive technologies that are patient friendly, easy to operate and safe are finding considerable uptake among elderly patients considering their interest in alternatives to medications and traditional sleep disorder tests. "There is a growing demand for devices that offer integration and connectivity in sleep centres and home settings," said Frost & Sullivan Healthcare Research Analyst Akanksha Joshi.

Subjects

Informations

Published by
Published 11 March 2014
Reads 3
Language English
Report a problem
Frost & Sullivan: Innovative Information Technology Awakens the Sleep Disorder Diagnostic Industry

PR Newswire

- Sales of ambulatory polysymnogram devices far outstrip sales of clinical devices

A large pool of undiagnosed patients and the growing population of the elderly in both Europe and North America point to a massive end-user market for sleep disorder diagnostics devices. The market is steadily drawing investors due to the visible tilt in preference from drugs to home care sleep tests that are more convenient and lack side effects.